Sequential catalytic nanomedicine augments synergistic chemodrug and chemodynamic cancer therapy-Reference-Cited by-同舟云学术

Sequential catalytic nanomedicine augments synergistic chemodrug and chemodynamic cancer therapy

Published:2019 Issue:4 Volume:4 Page:890-901
ISSN:2055-6756
Container-title:Nanoscale Horizons
language:en
Short-container-title:Nanoscale Horiz.

Author:

Liang Ruijie¹²³⁴⁵,Chen Yu⁶⁷⁸⁹¹⁰^ORCID,Huo Minfeng⁶⁷⁸⁹¹⁰,Zhang Jun¹¹¹²¹⁰,Li Yongsheng¹²³⁴⁵^ORCID

Affiliation:

1. Lab of Low-Dimensional Materials Chemistry

2. Key Laboratory for Ultrafine Materials of Ministry of Education

3. School of Materials Science and Engineering

4. East China University of Science and Technology

5. Shanghai 200237

6. State Key Laboratory of High Performance Ceramics and Superfine Microstructure

7. Shanghai Institute of Ceramics

8. Chinese Academy of Sciences

9. Shanghai 200050

10. China

11. Department of Radiology, Huashan Hospital Affiliated to Fudan University

12. Shanghai 200040

Abstract

Tumor microenvironment (TME)-specific nanocatalysts for augmented synergistic chemodrug and chemodynamic cancer therapy have been constructed, which feature an optimized effect on TME features. Systematic in vitro and in vivo tests have revealed the high therapeutic activity of the nanocatalysts for substantially suppressing tumor growth.

Funder

National Natural Science Foundation of China

China Association for Science and Technology

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science

Link

http://pubs.rsc.org/en/content/articlepdf/2019/NH/C9NH00008A

Reference68 articles.

1. Supramolecular chemotherapy based on host–guest molecular recognition: a novel strategy in the battle against cancer with a bright future

2. Overcoming the Achilles' heel of photodynamic therapy